SKYCLARYS 50 mg/1
omaveloxolone · CAPSULE · Biogen
Skyclarys (omaveloxolone) is an oral capsule medication used to treat Friedreich's ataxia, a rare inherited neurological disorder that affects movement and coordination. It works by activating certain cellular pathways that help protect nerve cells from damage.
Key Facts
- Brand Name
- SKYCLARYS
- Generic Name
- omaveloxolone
- NDC Code (Product)
64406-250- Manufacturer
- Biogen
- Strength
- 50 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA216718
- Drug Class
- Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]
- Marketing Start
- 02/28/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is SKYCLARYS used for?
Skyclarys (omaveloxolone) is an oral capsule medication used to treat Friedreich's ataxia, a rare inherited neurological disorder that affects movement and coordination. It works by activating certain cellular pathways that help protect nerve cells from damage.
Is SKYCLARYS a controlled substance?
SKYCLARYS is not classified as a controlled substance by the DEA.
What is the generic name for SKYCLARYS?
The generic name for SKYCLARYS is omaveloxolone. There are no other listed brand versions of omaveloxolone.
What is the NDC code for SKYCLARYS 50 mg/1?
The NDC (National Drug Code) for SKYCLARYS 50 mg/1 is 64406-250, listed by Biogen.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)